|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2.520 NOK | +0.80% |
|
-1.37% | -62.89% |
| 07-03 | Elliptic Laboratories Announces Commercial Device Launch Incorporating AI Virtual Smart Sensor Platform | CI |
| 06-15 | Elliptic Labs to Deploy Proximity Sensor Technology for Smartphone Vendor | MT |
Projected Income Statement: Elliptic Laboratories ASA
Annual
Quarterly
Annual
Quarterly
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Net sales 1 | 63.04 | 52.06 | 68.32 | 131.9 | 102.7 | 102.2 | 121.3 | 151.3 |
| Change | - | -17.41% | 31.23% | 93.08% | -22.12% | -0.54% | 18.71% | 24.7% |
| EBITDA 1 | -2.829 | -30.81 | -33.52 | 25.12 | -20.68 | -5.917 | 17.56 | 36.17 |
| Change | - | -989.22% | -8.78% | 174.94% | -182.33% | 71.39% | 396.84% | 105.94% |
| EBIT 1 | -11.14 | -42.13 | -49.74 | 4.71 | -45.44 | -31.5 | -8.792 | 7.947 |
| Change | - | -278.2% | -18.07% | 109.47% | -1,064.84% | 30.69% | 72.09% | 190.39% |
| Interest Paid | -5.683 | - | - | - | - | - | - | - |
| Earnings before Tax (EBT) 1 | -13.09 | -39.3 | -46.86 | 17.05 | -58.24 | -34.53 | -8.288 | 8.029 |
| Change | - | -200.18% | -19.22% | 136.38% | -441.61% | 40.71% | 76% | 196.87% |
| Net income 1 | -11.16 | -32.04 | -37.85 | 8.96 | -139 | -32.05 | -6.465 | 6.262 |
| Change | - | -187.2% | -18.13% | 123.67% | -1,651.36% | 76.94% | 79.83% | 196.87% |
| Announcement Date | 3/10/22 | 2/17/23 | 2/15/24 | 2/27/25 | 2/26/26 | - | - | - |
1NOK in Million
Estimates
Forecast Balance Sheet: Elliptic Laboratories ASA
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Net Debt 1 | -201 | -166 | -89.7 | -57 | -43.1 | -67 | -50.9 | -43.1 |
| Change | - | 17.41% | 45.96% | 36.45% | 24.39% | -55.6% | 24.03% | 15.32% |
| Announcement Date | 3/10/22 | 2/17/23 | 2/15/24 | 2/27/25 | 2/26/26 | - | - | - |
1NOK in Million
Estimates
Cash Flow Forecast: Elliptic Laboratories ASA
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| CAPEX 1 | 17.61 | 23.33 | 25.48 | 30.72 | 29.08 | 25 | 25 | 28 |
| Change | - | 32.46% | 9.22% | 20.56% | -5.32% | -14.04% | 0% | 12% |
| Free Cash Flow (FCF) 1 | -28.43 | -36.08 | - | - | -23.09 | -25 | -10 | -1 |
| Change | - | -26.91% | - | - | - | -8.28% | 60% | 90% |
| Announcement Date | 3/10/22 | 2/17/23 | 2/15/24 | 2/27/25 | 2/26/26 | - | - | - |
1NOK in Million
Estimates
Forecast Financial Ratios: Elliptic Laboratories ASA
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
Profitability | ||||||||
| EBITDA Margin (%) | -4.49% | -59.19% | -49.06% | 19.04% | -20.13% | -5.79% | 14.48% | 23.91% |
| EBIT Margin (%) | -17.67% | -80.92% | -72.81% | 3.57% | -44.23% | -30.82% | -7.25% | 5.25% |
| EBT Margin (%) | -20.77% | -75.49% | -68.58% | 12.92% | -56.68% | -33.79% | -6.83% | 5.31% |
| Net margin (%) | -17.7% | -61.54% | -55.4% | 6.79% | -135.3% | -31.36% | -5.33% | 4.14% |
| FCF margin (%) | -45.11% | -69.31% | - | - | -22.47% | -24.47% | -8.24% | -0.66% |
| FCF / Net Income (%) | 254.87% | 112.62% | - | - | 16.61% | 78% | 154.69% | -15.97% |
Profitability | ||||||||
| ROA | - | - | - | - | - | - | - | - |
| ROE | -4.2% | -9.7% | -11.96% | 2.84% | -54.86% | - | - | 2.76% |
Financial Health | ||||||||
| Leverage (Debt/EBITDA) | - | - | - | - | - | - | - | - |
| Debt / Free cash flow | - | - | - | - | - | - | - | - |
Capital Intensity | ||||||||
| CAPEX / Current Assets (%) | 27.94% | 44.81% | 37.29% | 23.28% | 28.31% | 24.47% | 20.61% | 18.51% |
| CAPEX / EBITDA (%) | -622.48% | -75.7% | -76.01% | 122.29% | -140.63% | -422.54% | 142.35% | 77.41% |
| CAPEX / FCF (%) | -61.94% | -64.64% | - | - | -125.96% | -100% | -250% | -2,800% |
Items per share | ||||||||
| Cash flow per share 1 | - | - | - | - | - | - | - | - |
| Change | - | - | - | - | - | - | - | - |
| Dividend per Share 1 | - | - | - | - | - | - | - | - |
| Change | - | - | - | - | - | - | - | - |
| Book Value Per Share 1 | 3.301 | 3.134 | 2.929 | 3.09 | 1.786 | 1.683 | 1.676 | 1.765 |
| Change | - | -5.06% | -6.53% | 5.5% | -42.22% | -5.74% | -0.41% | 5.33% |
| EPS 1 | -0.11 | -0.31 | -0.36 | 0.09 | -1.32 | -0.2475 | -0.0494 | 0.0473 |
| Change | - | -181.82% | -16.13% | 125% | -1,566.67% | 81.25% | 80.05% | 195.81% |
| Nbr of stocks (in thousands) | 103,842 | 104,074 | 104,838 | 105,275 | 105,287 | 126,337 | 126,337 | 126,337 |
| Announcement Date | 3/10/22 | 2/17/23 | 2/15/24 | 2/27/25 | 2/26/26 | - | - | - |
1NOK
Estimates
| 2026 * | 2027 * | |
|---|---|---|
| P/E | -10.2x | -51.1x |
| PBR | 1.5x | 1.5x |
| EV / Sales | 2.46x | 2.21x |
| Yield | - | - |
EPS & Dividend
Y-o-Y evolution of P/E
Year-on-year evolution of the Yield
Sell
Buy

Mean consensus
OUTPERFORM
Number of Analysts
1
Last Close Price
2.520NOK
Average target price
4.800NOK
Spread / Average Target
+90.48%
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- ELABS Stock
- Financials Elliptic Laboratories ASA
Select your edition
All financial news and data tailored to specific country editions
















